Study Site — Austin, Texas

Study Site is a clinical research site located in Austin, Texas, United States 78756.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Study Site has participated in 9 clinical trials.

Therapeutic areas: Schizophrenia, Influenza, Type 2 Diabetes.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc., Seqirus, Intarcia Therapeutics.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site?

Study Site has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site conducted?

Study Site has 9 clinical trials on record. Their work covers Schizophrenia, Influenza, Type 2 Diabetes.

Is Study Site accredited by Crixeo Health?

Yes — Study Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.